BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20051848)

  • 21. Growth factor signaling pathways in vascular development.
    Tallquist MD; Soriano P; Klinghoffer RA
    Oncogene; 1999 Dec; 18(55):7917-32. PubMed ID: 10630644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation.
    Gavi S; Shumay E; Wang HY; Malbon CC
    Trends Endocrinol Metab; 2006 Mar; 17(2):48-54. PubMed ID: 16460957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A; Dunk C; Kniss D; Wilkes M
    Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functions of the VEGF/VEGF receptor system in the vascular system.
    Breier G
    Semin Thromb Hemost; 2000; 26(5):553-9. PubMed ID: 11129412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
    Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
    Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth factors and the epididymis.
    Tomsig JL; Turner TT
    J Androl; 2006; 27(3):348-57. PubMed ID: 16474016
    [No Abstract]   [Full Text] [Related]  

  • 30. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
    Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.
    Kim HJ; Kim TY
    Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension.
    Jamroz-Wiśniewska A; Wójcicka G; Łowicka E; Ksiazek M; Bełtowski J
    Biochem Pharmacol; 2008 Apr; 75(8):1623-38. PubMed ID: 18282556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular signaling through cholesterol-rich domains: implications in hypertension.
    Callera GE; Montezano AC; Yogi A; Tostes RC; Touyz RM
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):90-104. PubMed ID: 17293683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of extracellular matrix in vascular remodeling of hypertension.
    Briones AM; Arribas SM; Salaices M
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):187-94. PubMed ID: 20040870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in intracellular signalling in hypertension.
    Touyz RM
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidants in receptor tyrosine kinase signal transduction pathways.
    Aslan M; Ozben T
    Antioxid Redox Signal; 2003 Dec; 5(6):781-8. PubMed ID: 14588151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel tyrosine kinase signaling pathways: implications in vascular remodeling.
    Batchu SN; Korshunov VA
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):122-7. PubMed ID: 22240445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular biology of ageing-Implications in hypertension.
    Harvey A; Montezano AC; Touyz RM
    J Mol Cell Cardiol; 2015 Jun; 83():112-21. PubMed ID: 25896391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogenic signaling cascades in glial tumors.
    Kapoor GS; O'Rourke DM
    Neurosurgery; 2003 Jun; 52(6):1425-34; discussion 1434-5. PubMed ID: 12762887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein tyrosine kinases in nervous system development.
    Maness PF; Cox ME
    Semin Cell Biol; 1992 Apr; 3(2):117-26. PubMed ID: 1319229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.